Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (131-140 of 239) with videos related to

Pageof 24
Sort By:
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
The Journal of Molecular Diagnostics : JMD|August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCRDaniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
Experimental Hematology & Oncology|June 13, 2025
Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Cellular and Molecular Life Sciences : CMLS|August 26, 2025
Immunoregulatory properties of cell free DNAFrancesca Ferrera, Tiziana Altosole, Samuele Tardito, et al.
Elife|July 16, 2020
Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531CheukMan C Au, John B Furness, Kara Britt, et al.
Nature Cancer|April 30, 2021
<i>FYN-TRAF3IP2</i> induces NF-κB signaling-driven peripheral T cell lymphomaChristine S Moon, Clara Reglero, Jose R Cortes, et al.
Nature Communications|January 31, 2017
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitorsFlorencia Cayrol, Pannee Praditsuktavorn, Tharu M Fernando, et al.
Cancer Cell|January 16, 2026
Axes of biological variation in diffuse large B cell lymphomaBoya Wang, George Wright, Julius C Enssle, et al.
Nature Communications|February 21, 2017
Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitorsFlorencia Cayrol, Pannee Praditsuktavorn, Tharu M Fernando, et al.
Nature Immunology|December 13, 2018
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesisKaterina Hatzi, Huimin Geng, Ashley S Doane, et al.
Pageof 24

Showing results (131-140 of 239) with videos related to

Sort By:
Pageof 24
Experimental Hematology & Oncology|August 10, 2023
Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
The Journal of Molecular Diagnostics : JMD|August 31, 2015
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCRDaniela Drandi, Lenka Kubiczkova-Besse, Simone Ferrero, et al.
Experimental Hematology & Oncology|June 13, 2025
Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myelomaCecilia Bandini, Elisabetta Mereu, Tina Paradzik, et al.
Cellular and Molecular Life Sciences : CMLS|August 26, 2025
Immunoregulatory properties of cell free DNAFrancesca Ferrera, Tiziana Altosole, Samuele Tardito, et al.
Elife|July 16, 2020
Three-dimensional growth of breast cancer cells potentiates the anti-tumor effects of unacylated ghrelin and AZP-531CheukMan C Au, John B Furness, Kara Britt, et al.
Nature Cancer|April 30, 2021
<i>FYN-TRAF3IP2</i> induces NF-κB signaling-driven peripheral T cell lymphomaChristine S Moon, Clara Reglero, Jose R Cortes, et al.
Nature Communications|January 31, 2017
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitorsFlorencia Cayrol, Pannee Praditsuktavorn, Tharu M Fernando, et al.
Cancer Cell|January 16, 2026
Axes of biological variation in diffuse large B cell lymphomaBoya Wang, George Wright, Julius C Enssle, et al.
Nature Communications|February 21, 2017
Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitorsFlorencia Cayrol, Pannee Praditsuktavorn, Tharu M Fernando, et al.
Nature Immunology|December 13, 2018
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesisKaterina Hatzi, Huimin Geng, Ashley S Doane, et al.
Pageof 24